For example, anti-PR3 antibodies were examined in 144 (15.45%) out of 932 SLE patients, and anti-MPO antibodies were assessed in 151 (16.2%) out of 932 SLE patients. The gene discussed is MPO; the disease is systemic lupus erythematosus.